BF-175

Overview

BF-175 is a selective SIRT1 agonist. BF175 increases SIRT1-mediated activation of PGC1-α , induces Apoptosis , induces Autophagy and inhibits SREBP activity. BF-175 protects against high glucose-mediated mitochondrial injury. BF-175 attenuates diabetic kidney disease progression. BF175 inhibits endometrial carcinoma.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Fatty Acid Synthase (FASN) | Products > Signaling Pathways > Sirtuin | Products > Signaling Pathways > PGC-1α | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-138443A
• CAS No.: 1333375-02-2
• Molecular Formula: C20H21BCl2O2
• Molecular Weight: 375.10
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source